Risk adjusted net present value: What is the current valuation of Bristol-Myers Squibb’s BMS-986446?
The revenue for BMS-986446 is expected to reach an annual total of $7 mn by 2040 in the US based off GlobalData’s Expiry Model. The drug’s revenue forecasts along with estimated costs are used to measure the value of an investment opportunity in that drug, …